AI for Equity Research: Cutting Two-Week Analyses to Ten Minutes

"I ran an analysis and it saved me 2 weeks of work in 10 minutes." Managing Director, LifeSci Capital

When the marginal cost of a piece of analysis drops by two orders of magnitude, the right question is not "how many analysts can we cut?" It is "what analyses become feasible that weren't feasible before?"

This post is about why AI for equity research changes the shape of the work, not just the speed.

§1. The economics of analyst time

A senior equity research analyst is expensive: base, bonus, and full carry, often $400K+ all-in at a mid-tier shop, multiples of that at a bulge-bracket bank. Their output is rationed by hours in the day. A coverage analyst running ten names spends most of their week on table-stakes maintenance: updating models, re-running comps, scanning catalysts, drafting quarterly previews. The high-leverage work (original thesis development, edge calls, deep diligence on new ideas) competes against the maintenance load.

The result is predictable. Maintenance gets done. Edge work gets squeezed. The marginal new idea takes two weeks from "interesting" to "publishable note," because the analyst can only borrow so many hours from the existing book.

§2. What "10x faster" actually changes

When AI cuts the time cost of a piece of analysis from two weeks to ten minutes, the immediate temptation is to read it as a labor-substitution story: same output, fewer analysts. That framing misses the point.

The work that used to take two weeks didn't fail because it was slow. It failed because it was rationed. There were always more analyses worth running than the analyst could fit into a quarter. When the cost drops, the rationing constraint relaxes, and analyses that previously sat below the line become feasible.

In practice, that looks like:

• Wider comp sets. Instead of three or four chosen comps, an analyst can pull thirty and let the data show which ones actually correlate.
• Deeper sensitivity tables. Instead of three operating cases, a model can run hundreds and surface the variables that actually move the answer.
• Catalyst monitoring across the full coverage universe. Instead of triaging by gut feel, every name gets continuous catalyst tracking with cited evidence.
• Pre-meeting prep that actually goes deep. Instead of skimming the last call transcript, an analyst walks into a management meeting with a synthesized thesis history, conflicting analyst views, and the questions nobody else is asking.

The right framing is capacity expansion. The same headcount produces more, and better, research.

§3. Why this only works with workflow-native AI

A general-purpose chatbot can answer one question well. It cannot reliably ship a quarterly preview or an initiation of coverage, because those deliverables have structure: section by section, evidence by evidence, with citations and house style enforced.

Workflow-native AI codifies the deliverable. The "preview" is a named workflow with defined inputs (transcripts, filings, consensus, internal models), a defined output schema (sections, charts, citation requirements), and verification rules (every claim must ground to a source). The analyst configures the workflow once. Every subsequent run produces the deliverable directly.

This is the difference between a tool that helps you write a memo and a tool that ships the memo. For production research, only the latter is interesting.

§4. The verification layer

The reason equity research can't run on generic AI is that the deliverable is read by people who will trade on it. A hallucinated revenue figure isn't a UX bug. It's a P&L event.

Production AI for equity research has to enforce citation grounding at the architectural level. Every claim in the output must trace to a source passage in the underlying corpus: the 10-K, the transcript, the broker note, the internal model. If a claim can't ground, it doesn't ship.

This is why citations matter beyond compliance: they are the only mechanism that lets a senior analyst trust the output enough to use it. An uncited claim is one the analyst has to re-verify by hand, which means the workflow saved them no time. A cited claim with a one-click jump to the source passage is a claim the analyst can review in seconds.

§5. The customer pattern

The LifeSci Capital quote at the top of this post is not a one-off. The pattern repeats: an analyst runs a workflow that previously took weeks, gets the output in minutes, spot-checks the citations, and ships. The first reaction is surprise at the speed. The second reaction (the more important one) is the realization that work they had been deferring for months is now feasible this afternoon.

That's the inflection. Not "AI does my job faster" but "AI changes the shape of the job."

§6. What firms get wrong

The most common procurement mistake is to evaluate AI tools on demo accuracy: can it answer this gotcha question correctly? That's the wrong test. A demo is a single query. Production research is thousands of queries embedded in a workflow with structured output, citation requirements, and a compliance log.

The right test is workflow throughput. Can the system produce a quarterly preview for every name in your coverage universe, with consistent house style and full citation, without an analyst rewriting half of it? That's the bar.

§7. Conclusion

The two-weeks-to-ten-minutes quote is real, but it understates the change. The point isn't that the same work happens faster. The point is that work which used to be rationed becomes routine, and the analyst's time gets reallocated from maintenance to edge.

That's the AI ROI conversation worth having for equity research. Not headcount substitution. Capacity expansion.